From Brick Dust To Breakthrough: The Power Of Enabled Formulation

From brick dust to breakthrough, enabled formulation can redefine what is possible for challenging molecules. In this episode of the AustinPx Live Series, we explore how bioavailability enhancement strategies transform poorly soluble, highly lipophilic compounds into viable oral dosage forms. Our team discusses how to evaluate formulation pathways, select the right enabling technology, and align performance goals with long-term scalability. Whether leveraging amorphous solid dispersions, lipid-based systems, micronization, or KinetiSol™, the focus remains the same: expand the formulation design space while maintaining a clear line of sight to manufacturability. This session highlights how thoughtful, data-driven development can improve exposure, reduce pill burden, and strengthen asset value without introducing unnecessary complexity. By integrating early performance insights with phase-appropriate CMC strategy, we help sponsors move from formulation challenge to clinical momentum with confidence. Where complex challenges meet tailored solutions. Learn more at www.austinpx.com.